Source: Mediators of Inflammation. Unidade: FMRP
Subjects: ARTRITE, PROSTAGLANDINAS, FATORES DE TRANSCRIÇÃO, RECEPTORES, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARREGARO, Vanessa et al. Therapeutic treatment of arthritic mice with 15-deoxy Δ12,14 -prostaglandin J2 (15d-PGJ2) ameliorates disease through the suppression of Th17 cells and the induction of CD4+ CD25- FOXP3+ cells. Mediators of Inflammation, v. 2016, 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/9626427. Acesso em: 06 nov. 2024.APA
Carregaro, V., Napimoga, M. H., Peres, R. S., Benevides, L., Sacramento, L. A., Pinto, L. G., et al. (2016). Therapeutic treatment of arthritic mice with 15-deoxy Δ12,14 -prostaglandin J2 (15d-PGJ2) ameliorates disease through the suppression of Th17 cells and the induction of CD4+ CD25- FOXP3+ cells. Mediators of Inflammation, 2016. doi:10.1155/2016/9626427NLM
Carregaro V, Napimoga MH, Peres RS, Benevides L, Sacramento LA, Pinto LG, Grespan R, Cunha TM, Silva JS da, Cunha F de Q. Therapeutic treatment of arthritic mice with 15-deoxy Δ12,14 -prostaglandin J2 (15d-PGJ2) ameliorates disease through the suppression of Th17 cells and the induction of CD4+ CD25- FOXP3+ cells [Internet]. Mediators of Inflammation. 2016 ; 2016[citado 2024 nov. 06 ] Available from: https://doi.org/10.1155/2016/9626427Vancouver
Carregaro V, Napimoga MH, Peres RS, Benevides L, Sacramento LA, Pinto LG, Grespan R, Cunha TM, Silva JS da, Cunha F de Q. Therapeutic treatment of arthritic mice with 15-deoxy Δ12,14 -prostaglandin J2 (15d-PGJ2) ameliorates disease through the suppression of Th17 cells and the induction of CD4+ CD25- FOXP3+ cells [Internet]. Mediators of Inflammation. 2016 ; 2016[citado 2024 nov. 06 ] Available from: https://doi.org/10.1155/2016/9626427
